Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 911.00
-73.50 (-7.47%)
Oct 21, 2026, 3:26 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 10.74 billion as of October 21, 2026. It is the 23,876th most valuable company in the world and the 1,526th biggest in India. Its market cap has increased by 35.43% in one year.
Market Cap
10.74B
Enterprise Value
10.82B
Revenue
8.54B
Global Rank
Country Rank
#1,526 India
PE Ratio
31.36
ChartMarket Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 10.74B, an increase of 305.61%. That is a compound annual growth rate of 50.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 10.74B | 31.14% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 15.70B |
| Infinium Pharmachem | 4.67B |
| Quest Laboratories | 1.48B |
| Sotac Pharmaceuticals | 995.05M |
| Vilin Bio Med | 812.06M |
| Zenith Drugs | 668.80M |
| Medicamen Organics | 325.44M |
| Sunrest Lifescience | 161.56M |